The aim of this study was to determine the effects of acute lung injury on the gut epithelium and examine mechanisms underlying changes in crypt proliferation and apoptosis. The relationship between severity and timing of lung injury to intestinal pathology was also examined.
P roliferation in the gut epithelium is restricted to the crypts of Lieberkuhn, and this production of new intestinal epithelial cells is balanced under basal conditions with cell loss through apoptosis and/or exfoliation (1, 2) . The relationship between proliferation and elimination is substantially altered in animal models of critical illness, although results vary depending on model. Sepsis from murine Pseudomonas aeruginosa pneumonia causes a time-dependent decrease in gut epithelial proliferation measured by Sphase cells labeled with 5-bromo-2'deoxyuridine (BrdU) with a simultaneous increase in crypt apoptosis (3) . Acute inflammation caused by intraperitoneal or intravenous injection of lipopolysaccharide (LPS) also causes decreased gut epithelial proliferation in rats (4) and increased apoptosis in mice, rats, or cats (5) (6) (7) (8) . In contrast, proliferation increases in rat cecal ligation and puncture, a model of ruptured appendicitis, when measured by incorporation of 3 H thymidine (9) , although this is also associated with an increase in gut epithelial apoptosis in mice (10, 11) .
The mechanisms that mediate gut epithelial proliferation and apoptosis in sys-temic inflammatory states are incompletely understood. Under basal conditions, the gut is host to a large number of resident bacteria and bacterial products such as LPS, but this does not result in derangements of gut physiology (12, 13) . This may be because the gut is typically hyporesponsive to LPS, and intestinal epithelial cells down-regulate expression of Toll-like receptor (TLR) 4 (14 -16) . However, in a murine model of colitis, TLR4 is up-regulated in the same tissue distribution as inflammation, which suggests that this LPS receptor may have a role in the inflammatory response (17) .
The effect that LPS has on modulating normal intestinal epithelial proliferation via TLR4 signaling is, in turn, mediated by tumor necrosis factor (TNF)-␣ produced by enterocytes in vitro (18) . Although there is little evidence to support a role for TNF-␣ in modulating intestinal epithelial proliferation in critical illness, it has been shown to modulate gut epithelial apoptosis in both thermal injury and infection. Mice subjected to a 30% body surface area burn typically have a three-fold increase in intestinal cell death, but this can be abrogated by giving anti-TNF-␣ antibody immediately following thermal injury (19) . Apoptosis induced by invasion of intestinal cells in vitro with either Escherichia coli or Salmonella dublin can also be partially blocked by giving anti-TNF-␣ antibody (20) .
Stress frequently alters the relationship between the cell cycle and cell death (21) (22) (23) . We have previously studied this relationship in the crypt epithelium in a high-mortality model of overwhelming infection and found that decreasing sepsis-induced crypt apoptosis can prevent decreases in intestinal epithelial proliferation. Mice that overexpress the antiapoptotic protein Bcl-2 in their gut epithelium have decreased crypt apoptosis compared with wild-type (WT) mice subjected to P. aeruginosa pneumonia and this is associated with a partial restitution in the proliferative capacity of the gut epithelium (3) .
It is well established that pulmonary injury can induce distant pathology, including abnormalities in the intestine. Injurious mechanical ventilation superimposed on a model of acid aspiration in rabbits induces villus apoptosis (24) . In addition, intratracheal injection of high-dose LPS induces both acute lung injury (ALI) and gut epithelial apoptosis in mice (25) . To study mechanisms of gut epithelial proliferation and apoptosis without the confounding factor of mortality, we gave mice a nonlethal lung injury to determine whether a) crypt proliferation is mediated by TLR4 or TNF-␣; b) increased apoptosis causes a compensatory change in gut epithelial proliferation that can be abrogated by decreasing cell death; c) severity of lung injury correlates with severity of abnormalities in the gut's proliferative capacity; and d) temporal changes in intestinal epithelial proliferation are linked to changes in apoptosis.
MATERIALS AND METHODS
Animals. Six-to twelve-week-old C57Bl/6, C3H/HeN, and C3H/HeJ mice were purchased from Charles River Laboratories (Wilmington, MA), Harlan International (Indianapolis, IN), and Jackson Laboratories (Bar Harbor, ME), respectively. Transgenic mice that overexpress Bcl-2 in their crypt epithelium (Fabpl-Bcl-2 mice) were generated on an FVB/N background (26) and were then backcrossed to C57Bl/6 mice for 11 generations. Mice were maintained on a 12-hr light-dark schedule in a specific pathogen-free environment and received standard laboratory mouse chow ad libitum. Details on all mice used in this study are contained in Table 1 . All animals examined were killed by cervical dislocation under halothane anesthesia at predetermined time points. All studies complied with National Institutes of Health guidelines for the use of laboratory animals and were approved by the Washington University Animal Studies Committee.
ALI Model.Intratracheal injection of LPS is a well-accepted model of ALI (27) (28) (29) (30) . Under halothane anesthesia, mice underwent a midline tracheal incision (25, 31, 32) and received an intratracheal injection of LPS (from E. coli 055:B5; Sigma, St. Louis, MO) diluted in 50 L of 0.9% NaCl. Commercially obtained LPS was not purified before intratracheal injection. Animals were held upright vertically for 10 secs to enhance delivery into the lungs. All doses of LPS were diluted in the same volume of 0.9% NaCl. Sham animals were handled identically but received an injection of 50 L of 0.9% NaCl alone. Following incision closure, mice were injected subcutaneously with 1 mL of 0.9% NaCl to compensate for fluid and insensible losses.
Antibody Treatment. A subset of C57Bl/6 mice received a single 250-g intraperitoneal injection of hamster monoclonal anti-TNF-␣ immunoglobulin (Ig) G or irrelevant hamster monoclonal IgG (TN3-19 and L2-3D9, respectively, generously provided by Dr. Robert D. Schreiber, Washington University School of Medicine) (33) immediately after induction of ALI. The timing of antibody injection was chosen because anti-TNF-␣ IgG has been shown to prevent burn-induced gut epithelial apoptosis when given immediately following thermal injury (19) .
Endotoxin Determination. LAL Pyrotell gel-clot kit (Associates of Cape Cod, Woods Hole, MA) was used according to manufacturer specifications to determine whether LPS was present in the bloodstream. A different lot of commercially available LPS was used for these experiments than for all others described in this article secondary to the availability of the reagent.
Bacteriologic Analysis. Blood for culture was obtained at the time of kill from the vena cava; 100 L was diluted 1:10 in sterile phosphate-buffered saline, and serial dilutions were cultured on blood agar and MacConkey plates. Plates were examined 24 hrs following incubation at 37°C.
Determination of Proliferation and Division.Mice were injected intraperitoneally with 200 L of BrdU (5 mg/mL diluted in 0.9% NaCl; Sigma) 2 hrs before kill to label cells in S-phase. Following kill, the small intestine was immediately removed, opened along the length of its cephalocaudal axis, and washed to remove luminal contents. Intestines were immediately placed in 10% buffered formalin where they were fixed for 24 hrs and then were rolled distal to proximal and placed in 70% ethanol. Immunohistochemical detection of BrdU was performed using a commercially available kit (BD PharMingen, San Diego, CA). M-phase cells were identified by the characteristic morphology of the mitotic spindle on sections stained with hematoxylin alone. Sand M-phase cells were quantified in the distal small intestine in 100 contiguous crypts from well-oriented crypt-villus units by an investigator blinded to sample identity. Determination of Apoptosis. Apoptotic cells were identified using active caspase-3 staining and morphologic analysis of hematoxylin and eosin (H&E)-stained sections. Active caspase-3 staining was performed as previously described (3, 34) . Briefly, paraffinembedded tissues were heated and rehydrated. Slides were incubated at 23°C in 3% H 2 O 2 in methanol for 10 mins and then microwaved in citrate buffer (pH 6.0) for 9 mins at 89°C. Sections were then incubated with polyclonal rabbit anti-active caspase-3 (1:100; Cell Signaling, Beverly, MA) for 1 hr at 23°C. This was followed by another incubation at 23°C with secondary biotinylated goat anti-rabbit antibody (1:200; Vector Laboratories, Burlingame, CA) and then VECTASTAIN ABC (Vector Laboratories), both at 23°C for 30 mins. Slides were developed with metal-enhanced diaminobenzidine solution and counterstained with hematoxylin and dehydrated. Apoptotic cells were identified on H&E-stained sections by characteristic nuclear fragmentation and cell shrinkage with condensed nuclei.
Lung Inflammation. Lungs were qualitatively assessed in H&E-stained sections for the presence of an inflammatory infiltrate and integrity of the alveolar architecture.
Statistical Analysis. Data from three or more groups were compared using one-way analysis of variance followed by the Newman-Keuls' multiple comparison test. Pairwise comparisons were made with the Student's t-test. Statistical analysis was performed using Prism (GraphPad Software, San Diego, CA). We considered p Ͻ .05 to be statistically significant.
RESULTS

ALI Decreases Crypt Proliferation and
Increases Apoptosis Independent of Severity of Injury. C57Bl/6 mice received an intratracheal injection of 150, 300, or 500 g of LPS or 0.9% NaCl (n ϭ 3/group) and were killed 12 hrs later. Histologic analysis of the lungs of sham animals demonstrated normal alveolar architecture in the typical lacy pattern with clear airspaces (Fig. 1A) .
In contrast, all animals that received LPS had dose-dependent evidence of lung injury. Animals injected with 150 or 300 g of LPS had moderate consolidation and fibrin deposition, whereas animals receiving 500 g had a substantial increase in inflammatory cells as well as hemorrhage ( Fig. 1, B-D) . C57Bl/6 mice given 150, 300, or 500 g of LPS or 0.9% NaCl (n ϭ 6/group) were also assayed for crypt proliferation and death 12 hrs later. Animals receiving lower doses of LPS had a statistically significant decrease in S-phase cells (p Ͻ .01 and p Ͻ .05, respectively), whereas those receiving the highest dose were statistically similar to sham animals ( Figs. 2A, 3A , and 3B). The number of M-phase cells also decreased 50% in animals receiving lower doses of LPS compared with sham, without an accompanying fall in animals receiving the highest dose (data not shown). The lack of correlation between lung injury severity and gut epithelial production was also noted with crypt apoptosis, where cell death was significantly increased in mice receiving 300 g but was unchanged in the animals with the highest degree of ALI (p Ͻ .05, Figs. 2B, 3C, and 3D). Based on these results, ALI was induced in all subsequent experiments with 300 g of LPS.
To verify that this was a model of sterile inflammation, blood cultures were performed on mice that received each of the three doses of LPS. All cultures were sterile (lower limit of detection, 10 colony-forming units/mL n ϭ 27 mice). In addition, all animals (n ϭ 4/group) were noted to have LPS in the bloodstream 12 hrs following intratracheal injection, regardless of the dose examined.
ALI-Induced Decreases in Cellular Proliferation Last Longer Than Increases in Apoptosis.
To determine whether early changes in the gut epithelium persist following the induction of ALI, C57Bl/6 mice given 300 g of LPS were killed 12, 24, or 36 hrs later. Sham animals injected with 0.9% NaCl were also killed 12, 24, or 36 postoperatively (n ϭ 6 all groups) to verify that intratracheal injection alone Neither intestinal epithelial proliferation nor cell death is altered in mice that receive 500 g despite the fact that these animals have the highest amounts of lung injury. did not alter crypt proliferation or death. Statistically significant decreases in Sphase cells were noted at both early and late time points in mice subjected to ALI (Fig. 4A) . A 25-50% decrease was also seen in M-phase cells at all time points (p values between .053 and .09), and there was a smaller than two-fold increase in the ratio of S-phase to M-phase cells between animals with ALI and sham littermates at all time points (data not shown). In contrast, apoptosis rose early, peaked at 24 hrs, and returned to baseline by 36 hrs (Fig. 4B) .
Mice That Lack Functional TLR4 Have Higher Levels of Gut Epithelial Proliferation Following ALI. C3H/HeN and C3H/HeJ mice (which are genetically identical except for a missense mutation in the TLR4 gene in C3H/HeJ animals) (35) (n ϭ 8 -9/group) were both given a single intratracheal injection of 300 g of commercially obtained unpurified LPS and were killed 24 hrs later. Of note, this time point is later than that used in the dose-response curve in Figure 2 and is based on the brisk apoptotic response demonstrated at this time point in Figure  4 . C3H/HeJ mice had a statistically significant increase in S-phase cells compared with C3H/HeN mice (p Ͻ .05, Fig.  5, A-C) . In contrast, apoptosis was similar in each group whether assayed by active caspase 3 (Fig. 5D ) or H&E (data not shown).
Since C3H/HeJ mice are hyporespon-sive to LPS, we also verified that they have the ability to mount a response to ALI. Intratracheal injection of LPS causes similar lung injury in C3H/HeN and C3H/ HeJ mice.
Gut Epithelial Proliferation and Death Are Not Altered by Giving a Single Dose of
Anti-TNF-␣ Antibody Immediately After ALI. C57Bl/6 mice were given either an intraperitoneal injection of anti-TNF-␣ antibody or an irrelevant monoclonal IgG immediately after induction of ALI. Animals (n ϭ 11/group) had similar levels of proliferation and apoptosis regardless of whether they received anti-TNF-␣ antibody ( Fig. 6 ) despite having similar levels of lung injury (data not shown).
Bcl-2 Has No Effect on Proliferation Despite Decreasing Apoptosis. Fabpl
Bcl-2 mice and their WT littermates on a C57Bl/6 genetic background (n ϭ 10 -11/ group) subjected to ALI were compared with sham-operated (n ϭ 6) animals. Overexpression of Bcl-2 completely prevents ALI-induced apoptosis (Fig. 7 , A-C; of note, our lab has previously shown this in mice on an FVB/N genetic background using 800 g of LPS at 12 hrs) (25) . Fabpl-Bcl-2 mice and WT mice had similar amounts of proliferation following ALI (Fig. 7D ).
DISCUSSION
This study demonstrates that ALI decreases crypt proliferation and increases intestinal apoptosis. The proliferation decrease is at least partially TLR4 dependent since C3H/HeJ mice have more Sphase cells than C3H/HeN mice following the induction of lung injury. However, giving a single dose of monoclonal anti-TNF-␣ antibody following ALI failed to alter the number of S-phase cells. Cell cycle and cell death are uncoupled in ALI as neither alterations in proliferation in C3H/HeJ mice nor decreases in apoptosis in Fabpl-Bcl-2 mice are accompanied by compensatory changes in cell death or production, respectively. Surprisingly, animals with the greatest severity of lung injury were the only ones that had no changes in intestinal epithelial proliferation or death.
These results expand our understanding of the mechanisms involved in the gut's response to ALI and how they differ from those seen in other models of critical illness. First, although gut levels of TLR4 are different between basal states and chronic inflammation (17) , the role of this receptor in the gut epithelium in acute illness was previously unknown. To examine this question, it was first important to show that C3H/HeJ mice would respond to lung injury induced by unpurified LPS since TLR4 is a receptor for this molecule (36, 37) . Our results demonstrate that ALI can be induced in the absence of TLR4 based on the fact that lung pathology was similarly abnormal in C3H/HeJ and C3H/HeN mice. Since C3H/ HeJ mice have more intestinal epithelial S-phase cells than C3H/HeN mice following ALI, we conclude that signaling through this receptor is at least partially responsible for alterations in crypt Sphase cells following pulmonary injury.
Our results do not support a definite role for TNF-␣ in the ALI-induced changes in either gut epithelial proliferation or apoptosis. This was somewhat surprising, since TNF-␣ has been shown to modulate LPS-induced enterocyte proliferation under basal conditions (18) and induce gut apoptosis in both thermal injury and direct bacterial invasion (19, 20) . However, the fact that the number of S-phase cells was similar regardless of whether WT C57Bl/6 mice (with intact TLR4 signaling) received monoclonal anti-TNF-␣ antibody suggests that TNF-␣ is not a major mediator of gut cell production or death in ALI. These negative results may be important since they suggest that the host response to critical illness and the mechanisms underlying this response vary widely depending on the animal model used (38) , an important consideration when developing therapeutic agents. However, our results must be interpreted with caution because we gave only a single dose of a single type of anti-TNF-␣ antibody at a single time point, and there may actually be a TNF-␣ effect that we failed to uncover using this strategy.
Our results also demonstrate that gut epithelial proliferation and apoptosis are uncoupled after ALI. Although numerous insults have been reported to alter crypt proliferation and apoptosis, they have rarely been studied simultaneously. In thermal injury, gut epithelial proliferation and death appear to be linked. A 30% burn causes increased small bowel proliferation with a simultaneous increase in apoptosis (39) . Gut epithelial proliferation and apoptosis also change in parallel after jejunoileal resection, with both responses being lost in Bax Ϫ/Ϫ mice (21) . In contrast, intestinal cell production and destruction are disparate in P. aeruginosa pneumonia, which causes a decrease in crypt proliferation with a simultaneous increase in apoptosis (3) . Although the results contained herein are grossly similar to those published in pneumonia, the kinetics are different. The ratio of S-to M-phase cells, a common method of studying cell cycle kinetics in the gut epithelium (40, 41) , increased less than two-fold between sham animals and mice with ALI whereas mice with pseudomonal sepsis have a sevenfold decrease in this ratio.
This absence of an association between proliferation and apoptosis is further demonstrated by our results demonstrating that changes in cell cycle do not alter cell death (and conversely changes in apoptosis do not alter proliferation). We have previously shown that prevent- ing gut apoptosis in overwhelming infection via overexpression of intestinal Bcl-2 lessens the decrease in sepsis-induced proliferation. However, neither the increase in S-phase cells in mice without functional TLR4 signaling nor the decreased number of apoptotic cells by Bcl-2 overexpression resulted in any compensatory changes that would indi-cate "crosstalk" between the cell cycle and cell death.
The most unexpected finding of these studies was that intensity of lung injury does not correspond to the severity of dysregulation in crypt proliferation or death. Previous studies have demonstrated that mice with a 30% burn have increased gut epithelial proliferation (as measured by proliferating cell nuclear antigen) (39) , whereas rats with a 60% burn have decreased gut epithelial proliferation (as measured by BrdU) (42) . Although it is difficult to compare data between different species, injuries, and proliferation assays, we assumed based on these results that mice receiving higher doses of intratracheal LPS would have and transgenic animal of the same strain that overexpresses Bcl-2 in its gut epithelium (B) demonstrates that Bcl-2 prevents LPS-induced apoptosis (arrows point to apoptotic cells). C, quantitation of crypt cell death by active caspase 3 24 hrs after intratracheal injection of LPS demonstrates that Fabpl-Bcl-2 mice have a three-fold decrease in apoptosis compared with WT animals and are similar to sham animals. *p Ͻ .05 compared with sham mice; #p Ͻ .02 compared with WT animals with acute lung injury. Similar quantitative results were obtained with hematoxylin and eosin. Quantitation of S-phase cells in these animals demonstrates that preventing apoptosis has no effect on the number of S-phase cells (D). further decreases in proliferation and increases in apoptosis compared with mice receiving lower doses. However, animals that received 500 g (which had the highest degree of lung injury) were the only ones with no quantitative abnormalities in the number of S-phase, M-phase, or apoptotic cells. We do not have a good explanation why animals with the biggest insult were the only ones whose intestines had no abnormalities in the variables measured.
This study has a number of limitations. First, it is possible that TNF-␣ actually mediates LPS-induced changes in proliferation, but we were unable to detect this. Although we were using a wellcharacterized antibody at a published dose, this does not exclude the possibility that a different antibody, repeated doses of the same antibody, or a different dose of the same antibody would have resulted in different effects. We also did not purify the LPS used in this study. It is well known that commercially available LPS may be contaminated with lipoproteins and peptidoglycan (and therefore signal via receptors other than TLR4). We therefore have not shown that ALI in this study is exclusively due to LPS injection since a contaminant may have caused the lung injury observed. Rather, we demonstrate that commercially available unpurified LPS causes ALI, and the degree of lung injury is similar regardless of whether TLR4 is present. Although we do not know if this effect is secondary to a contaminant, the same LPS was used in both groups, resulting in similar levels of lung injury but different levels of intestinal epithelial proliferation in C3H/HeJ and C3H/HeN mice. It is possible that the reason lung injury was independent of TLR4 status was due to the fact that it was caused by a contaminant in unpurified LPS. Although this does not negate the fact that LPS was clearly present in the bloodstream in all animals and could be responsible for the difference in intestinal proliferation in C3H/HeJ and C3H/ HeN mice, our results must be interpreted with caution.
Interpreting a relationship (or lack thereof) between lung injury and intestinal pathology must be made with caution since we did not examine systemic inflammation in this study. Although we show that mice that receive 500 g of LPS have more lung injury than mice that receive 150 g, this does not inherently mean that local inflammatory changes in the lung are reflected systemically. Although we believe it is unlikely that higher doses of LPS cause more severe lung injury but less systemic inflammation, it is possible that unknown antiproliferative and/or proapoptotic factors are released at a higher level by the injured lungs in animals that received higher doses of LPS. Since LPS is present in the bloodstream of all animals, we also cannot rule out that the results obtained are secondary to endotoxemia alone independent of ALI. We believe this is unlikely since cytokines and lung injury differ substantially between mice given LPS via intratracheal or intraperitoneal routes (24, 43) . However, even if our results reflect a combination of both ALI and endotoxemia, each represents a noninfectious inflammatory insult with relevance to critical illness, and our overall conclusions are minimally altered by the relative contributions of each. Finally, we cannot know the biological significance of altered gut epithelial proliferation in this nonlethal model of ALI. We speculate that a decrease in production of new cells in the proliferating component of the intestinal epithelium may be detrimental to the host via altered permeability, via translocation of toxic substances into the mesenteric lymph, or via immunomodulation; however, additional studies are required to address the functional significance of our findings.
Despite these limitations, these results give new insights into how ALI decreases gut epithelial proliferation while increasing crypt apoptosis. They also demonstrate that even if pathology in one organ leads to a systemic response with resultant distant organ injury, the severity of the initial response does not predict what the secondary effect will be. Further studies of the gut's response to critical care models of increasing mortality should help determine whether similar results are found in more lethal injuries. 
